Chronic urticaria and Helicobacter pylori.

Background: Helicobacter pylori (HP) have recently emerged as a novel eliciting factor for chronic urticaria (CU). The possible association between HP and CU has enormous potential, as eradicating HP could cure CU.Aims and Objectives: We conducted a study to assess the prevalence of HP infection and...

Descripción completa

Detalles Bibliográficos
Publicado en:Indian Journal of Medical Sciences Vol. 62; no. 4; pp. 157 - 163
Autores principales: Yadav MK, Rishi JP, Nijawan S, Yadav, Mukesh K, Rishi, Jai P, Nijawan, S
Formato: research Journal Article
Publicado: Scientific Scholar LLC Apr2008
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105546429&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105546429
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00195359
        SV7
      jtl: Indian Journal of Medical Sciences
      issn: 00195359
      maglogo: N
    pubinfo:
      dt: Apr2008
      vid: 62
      iid: 4
      pid: 56013
      pub: Scientific Scholar LLC
      place: Pittsford, New York
    artinfo:
      ui:
        105546429
        NLM18445982
        2009917337
        10.4103/0019-5359.40579
        NLM18445982
        105546429
      ppf: 157
      ppct: 6
      formats:
      tig:
        atl: Chronic urticaria and Helicobacter pylori.
      aug:
        au:
          Yadav MK
          Rishi JP
          Nijawan S
          Yadav, Mukesh K
          Rishi, Jai P
          Nijawan, S
        affil: Department of Medicine, SMS Medical College, Jaipur, India
      sug:
        subj:
          Helicobacter Infections Epidemiology
          Helicobacter Pylori
          Urticaria Epidemiology
          Adolescence
          Adult
          Amoxicillin Therapeutic Use
          Case Control Studies
          Chronic Disease
          Comorbidity
          Drug Therapy, Combination
          Female
          Helicobacter Infections Drug Therapy
          Helicobacter Infections Microbiology
          Incidence
          India
          Male
          Metronidazole Therapeutic Use
          Middle Age
          Omeprazole Therapeutic Use
          Quality of Life
          Questionnaires
          Treatment Outcomes
          Urticaria Drug Therapy
          Urticaria Microbiology
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: Helicobacter pylori (HP) have recently emerged as a novel eliciting factor for chronic urticaria (CU). The possible association between HP and CU has enormous potential, as eradicating HP could cure CU.Aims and Objectives: We conducted a study to assess the prevalence of HP infection and effect of bacterium eradication on skin lesions in patients of chronic idiopathic urticaria (CIU).Settings and Design: Four hundred sixty patients of CU attending the allergy clinic, SMS hospital, Jaipur during the period February 6, 2004, to February 6, 2006, were screened for possible eliciting factors. Patients with CIU were enrolled and others were excluded.Materials and Methods: Sixty-eight patients of CIU and similar number of age and sex matched controls, attending the allergy clinic, SMS Hospital, Jaipur were enrolled in the study. All patients underwent endoscopy with antral biopsy for urease and histopathology to identify HP-associated gastritis. Infected patients were given HP eradication therapy. Eradication of bacterium was confirmed by fecal antigen assay. Subjective response to treatment was judged using chronic urticaria quality-of-life questionnaire (CU-Q 2 oL) while objective response to treatment was judged by need for 'rescue medication' (antihistaminics).Statistical Analysis: Data were analyzed using Chi square and paired 't' test for their level of significance.Results: HP associated gastritis was present in 48 (70.58%) patients, out of which 39 (81.25%) patients responded to eradication therapy. Ten (50.00%) patients without HP associated gastritis showed response to symptomatic therapy. Overall 49 (72.05%) patients responded and 19 (27.94%) showed no response. The value of chi2 was 28.571 (P = 0.003), which showed significant association between presence of HP and response to eradication regimen.Conclusion: The response of HP eradication therapy in infected patients of CIU is significant. HP should be included in diagnostic workup of patients with CIU.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N